Medican Enterprises (MDCN) Stock Price, News & Analysis

Company Overview

Medican Enterprises, Inc., a bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector. The company intends to invest in business of growing, marketing, research and development, training, distribution, and retail sale of medical and recreational marijuana in the United States and Canada. Medican Enterprises, Inc. was founded in 1988 and is headquartered in Las Vegas, Nevada.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0001
• Volume: 1.34 million shs
• Average Volume: 1.08 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MDCN Stock Analysis - Frequently Asked Questions

How have MDCN shares performed this year?

Medican Enterprises' stock was trading at $0.0001 on January 1st, 2025. Since then, MDCN stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here.

How do I buy shares of Medican Enterprises?

Shares of MDCN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Medican Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medican Enterprises investors own include Enzolytics (ENZC), Enterprise Products Partners (EPD), Vapor (HCMC), Hpil (HPIL), Asia Broadband (AABB), Anthera Pharmaceuticals (ANTH).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Real Estate
• Industry: Real Estate Services
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:MDCN
• CIK: N/A
• Web: www.medicaninc.com
• Phone: (313) 703-7873
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A